Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorNational University of Singapore

About this trial

The goal of this two-armed, parallel-design, pre-/post-intervention assessment clinical trial is to learn if a digital and interactive website helps to improve advance care planning (ACP) engagement among caregivers of patients with serious illness. The main questions it aims to answer are:

Does the website increase ACP engagement of caregivers of patients with serious illness? Researchers will compare the digital and interactive website to the usual care (a digital booklet) to see if the digital intervention works to improve ACP engagement among caregivers.

Participants who are caregivers will:

* Be introduced to a digital website and asked to explore the site over the course of the study. * Complete four self-administered questionnaires (baseline, one-week, six-week, and six-month).

Participants who are patients will not have any intervention assigned and will only have their observational data collected through four interviewer-administered questionnaires (baseline, one-week, six-week, and six-month)

Eligibility criteria

Qualifiers

Singapore resident aged 21years and above,

patient able to identify one main caregiver in the care and medical decision-making for the patient;

patient able to communicate in either English, Chinese, Malay or Tamil;

patient meeting one of the following illness criteria: 4a. Patients with brain tumours: histological and/or radiological diagnosis of glioma or brain metastases.

Disqualifiers

Patients unable to identify a caregiver who is a medical decision-maker,

Patients are currently or was previously healthcare workers; or

Patients are diagnosed with dementia or deemed cognitively impaired as determined by the Abbreviated Mental Test.

caregivers are identified as a medical decision-maker for the patient

Trial design

Treatments tested in this trial

  • Careverse
  • Usual Care

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators

National University of Singapore

Lead sponsor

National University Hospital, Singapore

Collaborator